Functional Enhancers Shape Extrachromosomal Oncogene Amplifications

Non-coding regions amplified beyond oncogene borders have largely been ignored. Using a computational approach, we find signatures of significant co-amplification of non-coding DNA beyond the boundaries of amplified oncogenes across five cancer types. In glioblastoma, EGFR is preferentially co-ampli...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Cell Ročník 179; číslo 6; s. 1330
Hlavní autoři:	Morton, Andrew R, Dogan-Artun, Nergiz, Faber, Zachary J, MacLeod, Graham, Bartels, Cynthia F, Piazza, Megan S, Allan, Kevin C, Mack, Stephen C, Wang, Xiuxing, Gimple, Ryan C, Wu, Qiulian, Rubin, Brian P, Shetty, Shashirekha, Angers, Stephane, Dirks, Peter B, Sallari, Richard C, Lupien, Mathieu, Rich, Jeremy N, Scacheri, Peter C
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 27.11.2019
Témata:	Acetylation Cell Line, Tumor Cell Survival - genetics Chromatin - metabolism Chromosomes, Human - genetics CRISPR-Cas Systems - genetics DNA, Neoplasm - genetics Enhancer Elements, Genetic ErbB Receptors - genetics ErbB Receptors - metabolism Gene Amplification Genes, Neoplasm Genetic Loci Glioblastoma - genetics Glioblastoma - pathology Histones - metabolism Humans Neuroglia - metabolism Oncogenes enhancer MYCN double minute glioblastoma epigenetic MYC oncogene amplification extrachromosomal DNA EGFR
ISSN:	1097-4172, 1097-4172
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Non-coding regions amplified beyond oncogene borders have largely been ignored. Using a computational approach, we find signatures of significant co-amplification of non-coding DNA beyond the boundaries of amplified oncogenes across five cancer types. In glioblastoma, EGFR is preferentially co-amplified with its two endogenous enhancer elements active in the cell type of origin. These regulatory elements, their contacts, and their contribution to cell fitness are preserved on high-level circular extrachromosomal DNA amplifications. Interrogating the locus with a CRISPR interference screening approach reveals a diversity of additional elements that impact cell fitness. The pattern of fitness dependencies mirrors the rearrangement of regulatory elements and accompanying rewiring of the chromatin topology on the extrachromosomal amplicon. Our studies indicate that oncogene amplifications are shaped by regulatory dependencies in the non-coding genome.
AbstractList	Non-coding regions amplified beyond oncogene borders have largely been ignored. Using a computational approach, we find signatures of significant co-amplification of non-coding DNA beyond the boundaries of amplified oncogenes across five cancer types. In glioblastoma, EGFR is preferentially co-amplified with its two endogenous enhancer elements active in the cell type of origin. These regulatory elements, their contacts, and their contribution to cell fitness are preserved on high-level circular extrachromosomal DNA amplifications. Interrogating the locus with a CRISPR interference screening approach reveals a diversity of additional elements that impact cell fitness. The pattern of fitness dependencies mirrors the rearrangement of regulatory elements and accompanying rewiring of the chromatin topology on the extrachromosomal amplicon. Our studies indicate that oncogene amplifications are shaped by regulatory dependencies in the non-coding genome. Non-coding regions amplified beyond oncogene borders have largely been ignored. Using a computational approach, we find signatures of significant co-amplification of non-coding DNA beyond the boundaries of amplified oncogenes across five cancer types. In glioblastoma, EGFR is preferentially co-amplified with its two endogenous enhancer elements active in the cell type of origin. These regulatory elements, their contacts, and their contribution to cell fitness are preserved on high-level circular extrachromosomal DNA amplifications. Interrogating the locus with a CRISPR interference screening approach reveals a diversity of additional elements that impact cell fitness. The pattern of fitness dependencies mirrors the rearrangement of regulatory elements and accompanying rewiring of the chromatin topology on the extrachromosomal amplicon. Our studies indicate that oncogene amplifications are shaped by regulatory dependencies in the non-coding genome.Non-coding regions amplified beyond oncogene borders have largely been ignored. Using a computational approach, we find signatures of significant co-amplification of non-coding DNA beyond the boundaries of amplified oncogenes across five cancer types. In glioblastoma, EGFR is preferentially co-amplified with its two endogenous enhancer elements active in the cell type of origin. These regulatory elements, their contacts, and their contribution to cell fitness are preserved on high-level circular extrachromosomal DNA amplifications. Interrogating the locus with a CRISPR interference screening approach reveals a diversity of additional elements that impact cell fitness. The pattern of fitness dependencies mirrors the rearrangement of regulatory elements and accompanying rewiring of the chromatin topology on the extrachromosomal amplicon. Our studies indicate that oncogene amplifications are shaped by regulatory dependencies in the non-coding genome.
Author	Piazza, Megan S Morton, Andrew R Gimple, Ryan C Bartels, Cynthia F Allan, Kevin C Scacheri, Peter C Lupien, Mathieu Wu, Qiulian Sallari, Richard C Angers, Stephane Rich, Jeremy N Rubin, Brian P Shetty, Shashirekha MacLeod, Graham Faber, Zachary J Dirks, Peter B Wang, Xiuxing Dogan-Artun, Nergiz Mack, Stephen C
Author_xml	– sequence: 1 givenname: Andrew R surname: Morton fullname: Morton, Andrew R organization: Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Case Comprehensive Cancer Center, Cleveland, OH 44106, USA – sequence: 2 givenname: Nergiz surname: Dogan-Artun fullname: Dogan-Artun, Nergiz organization: Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada – sequence: 3 givenname: Zachary J surname: Faber fullname: Faber, Zachary J organization: Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Case Comprehensive Cancer Center, Cleveland, OH 44106, USA – sequence: 4 givenname: Graham surname: MacLeod fullname: MacLeod, Graham organization: Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada – sequence: 5 givenname: Cynthia F surname: Bartels fullname: Bartels, Cynthia F organization: Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Case Comprehensive Cancer Center, Cleveland, OH 44106, USA – sequence: 6 givenname: Megan S surname: Piazza fullname: Piazza, Megan S organization: Center for Human Genetics Laboratory, University Hospitals, Cleveland, OH 44106, USA – sequence: 7 givenname: Kevin C surname: Allan fullname: Allan, Kevin C organization: Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Case Comprehensive Cancer Center, Cleveland, OH 44106, USA – sequence: 8 givenname: Stephen C surname: Mack fullname: Mack, Stephen C organization: Department of Pediatrics, Division of Hematology and Oncology, Baylor College of Medicine, Texas Children's Hospital, Houston, TX 77030, USA – sequence: 9 givenname: Xiuxing surname: Wang fullname: Wang, Xiuxing organization: Department of Medicine, Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA 92037, USA – sequence: 10 givenname: Ryan C surname: Gimple fullname: Gimple, Ryan C organization: Department of Medicine, Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA 92037, USA; Department of Pathology, Case Western Reserve University, Cleveland, OH 44120, USA – sequence: 11 givenname: Qiulian surname: Wu fullname: Wu, Qiulian organization: Department of Medicine, Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA 92037, USA – sequence: 12 givenname: Brian P surname: Rubin fullname: Rubin, Brian P organization: Departments of Anatomic Pathology and Molecular Genetics, Cleveland Clinic, Lerner Research Institute and Taussig Cancer Center, Cleveland, OH 44195, USA – sequence: 13 givenname: Shashirekha surname: Shetty fullname: Shetty, Shashirekha organization: Center for Human Genetics Laboratory, University Hospitals, Cleveland, OH 44106, USA – sequence: 14 givenname: Stephane surname: Angers fullname: Angers, Stephane organization: Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, ON M5S 3M2, Canada; Department of Biochemistry, Faculty of Medicine, University of Toronto, Toronto, ON M5G 0A4, Canada – sequence: 15 givenname: Peter B surname: Dirks fullname: Dirks, Peter B organization: Developmental and Stem Cell Biology Program and Arthur and Sonia Labatt Brain Tumour Research Centre, The Hospital for Sick Children, Toronto, ON M5G 0A4, Canada; Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada – sequence: 16 givenname: Richard C surname: Sallari fullname: Sallari, Richard C organization: Axiotl Inc., Tucson, AZ 85701, USA – sequence: 17 givenname: Mathieu surname: Lupien fullname: Lupien, Mathieu organization: Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Ontario Institute for Cancer Research, Toronto, ON M5G 0A3, Canada; Department of Medical Biophysics, University of Toronto, Toronto, ON M5S 1A8, Canada – sequence: 18 givenname: Jeremy N surname: Rich fullname: Rich, Jeremy N email: drjeremyrich@gmail.com organization: Department of Medicine, Division of Regenerative Medicine, University of California, San Diego, La Jolla, CA 92037, USA; Department of Neurosciences, University of California, San Diego, School of Medicine, La Jolla, CA 92037, USA. Electronic address: drjeremyrich@gmail.com – sequence: 19 givenname: Peter C surname: Scacheri fullname: Scacheri, Peter C email: pxs183@case.edu organization: Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Case Comprehensive Cancer Center, Cleveland, OH 44106, USA. Electronic address: pxs183@case.edu
BackLink	https://www.ncbi.nlm.nih.gov/pubmed/31761532$$D View this record in MEDLINE/PubMed
BookMark	eNpNkE1Lw0AQhhdR7If-AQ-So5fEmd3sbnIspVWh0IN6DpPt1qYkuzGbgP57U6zgaYbheQeed8YunXeWsTuEBAHV4zExtq4TDpiPhwREfsGmCLmOU9T88t8-YbMQjgCQSSmv2USgVigFn7LlenCmr7yjOlq5AzljuxC9Hqi10eqr78gcOt_44JsR2DrjP6yz0aJp62pfGTolww272lMd7O15ztn7evW2fI4326eX5WITGynTPpY7RZmxgKhxL5TN0tLqnCswKZHQkiADAqSMlICMtCplWaYyJbEDgQb5nD38_m07_znY0BdNFU4VkLN-CAUftXKleS5G9P6MDmVjd0XbVQ1138WfOP8BcfNc1g
CitedBy_id	crossref_primary_10_1038_s41389_023_00476_0 crossref_primary_10_3389_fcell_2021_792555 crossref_primary_10_31083_j_fbl2707207 crossref_primary_10_1186_s13287_025_04516_x crossref_primary_10_1002_advs_202501934 crossref_primary_10_3389_fonc_2020_625332 crossref_primary_10_1016_j_semcdb_2021_11_015 crossref_primary_10_1016_j_cca_2024_117822 crossref_primary_10_1016_j_gde_2020_11_010 crossref_primary_10_1016_j_xcrm_2025_102164 crossref_primary_10_1038_s41556_020_00620_7 crossref_primary_10_3390_genes12101533 crossref_primary_10_1016_j_gde_2021_01_001 crossref_primary_10_1186_s12967_021_02927_x crossref_primary_10_7554_eLife_81412 crossref_primary_10_3390_cells12131745 crossref_primary_10_1038_s41467_024_45972_y crossref_primary_10_1007_s00018_021_03926_3 crossref_primary_10_7554_eLife_80207 crossref_primary_10_1158_2159_8290_CD_20_0936 crossref_primary_10_1146_annurev_cancerbio_070620_092730 crossref_primary_10_1371_journal_pbio_3003275 crossref_primary_10_1016_j_neo_2024_101025 crossref_primary_10_1007_s13577_025_01178_y crossref_primary_10_1038_s41588_024_01949_7 crossref_primary_10_1038_s41416_024_02664_0 crossref_primary_10_1093_nar_gkaa747 crossref_primary_10_1016_j_scib_2025_04_033 crossref_primary_10_1002_cam4_4749 crossref_primary_10_1002_jemt_24780 crossref_primary_10_3389_fimmu_2021_780779 crossref_primary_10_1002_adbi_202400433 crossref_primary_10_1158_2159_8290_CD_23_1189 crossref_primary_10_3390_biom14091045 crossref_primary_10_1101_gr_278418_123 crossref_primary_10_1038_s41588_021_01000_z crossref_primary_10_1038_s41467_020_19452_y crossref_primary_10_1007_s10238_024_01348_6 crossref_primary_10_1093_nar_gkab1104 crossref_primary_10_1146_annurev_genom_120821_100535 crossref_primary_10_1038_s41587_022_01568_9 crossref_primary_10_1038_s41467_024_50387_w crossref_primary_10_1093_nar_gkad105 crossref_primary_10_1016_j_critrevonc_2021_103477 crossref_primary_10_3389_fonc_2025_1569548 crossref_primary_10_1111_nan_12612 crossref_primary_10_1002_ctm2_1393 crossref_primary_10_1111_cge_13896 crossref_primary_10_1038_s41587_022_01289_z crossref_primary_10_1002_bies_202200242 crossref_primary_10_1016_j_heliyon_2023_e21327 crossref_primary_10_1016_j_ccell_2021_03_006 crossref_primary_10_1038_s12276_024_01236_9 crossref_primary_10_1038_s41586_021_04116_8 crossref_primary_10_3389_fonc_2022_934159 crossref_primary_10_1093_bib_bbac422 crossref_primary_10_1038_s41571_022_00679_1 crossref_primary_10_1038_s41423_023_01048_3 crossref_primary_10_1038_s41588_024_01826_3 crossref_primary_10_3389_fgene_2025_1641162 crossref_primary_10_7554_eLife_88895_3 crossref_primary_10_1016_j_bbcan_2020_188378 crossref_primary_10_1158_2159_8290_CD_21_1376 crossref_primary_10_1038_s41422_024_01054_8 crossref_primary_10_1093_gigascience_giab080 crossref_primary_10_1360_SSV_2025_0113 crossref_primary_10_1002_1878_0261_13735 crossref_primary_10_1146_annurev_pathmechdis_051821_114223 crossref_primary_10_1186_s13045_020_00960_9 crossref_primary_10_1097_HEP_0000000000000435 crossref_primary_10_1101_gr_279123_124 crossref_primary_10_1038_s41568_022_00486_x crossref_primary_10_1038_s41588_020_0664_8 crossref_primary_10_1002_ctm2_1351 crossref_primary_10_1158_0008_5472_CAN_21_2056 crossref_primary_10_1016_j_gde_2022_101911 crossref_primary_10_1016_j_csbj_2023_05_017 crossref_primary_10_1038_s41588_023_01551_3 crossref_primary_10_7554_eLife_88895 crossref_primary_10_1038_s41576_022_00521_5 crossref_primary_10_3389_fvets_2021_693641 crossref_primary_10_1016_j_bbcan_2021_188551 crossref_primary_10_1016_j_cbi_2022_110000 crossref_primary_10_1080_19491034_2022_2143106 crossref_primary_10_1002_ctm2_70445 crossref_primary_10_3390_cancers14122866 crossref_primary_10_1186_s13045_022_01271_x crossref_primary_10_1038_s41568_024_00669_8 crossref_primary_10_3390_cancers13215528 crossref_primary_10_1016_j_csbj_2022_10_033 crossref_primary_10_1371_journal_pone_0324438 crossref_primary_10_3390_ijms26020818 crossref_primary_10_3390_biom14040488 crossref_primary_10_1016_j_trecan_2025_06_004 crossref_primary_10_1158_0008_5472_CAN_22_1858 crossref_primary_10_1186_s12931_024_02808_z crossref_primary_10_3389_fonc_2023_1271851 crossref_primary_10_1093_neuonc_noab231 crossref_primary_10_1016_j_gde_2022_101919 crossref_primary_10_1016_j_ccell_2020_01_008 crossref_primary_10_1016_j_bbcan_2022_188843 crossref_primary_10_1016_j_heliyon_2024_e36659 crossref_primary_10_1038_s41467_025_59805_z crossref_primary_10_3389_fgene_2022_859513 crossref_primary_10_1073_pnas_2102842118 crossref_primary_10_1186_s13072_023_00502_w crossref_primary_10_3389_fgene_2022_918379 crossref_primary_10_1007_s11427_024_2710_3 crossref_primary_10_1158_2159_8290_CD_22_0787 crossref_primary_10_3390_ijms22020786 crossref_primary_10_1038_s41588_023_01386_y crossref_primary_10_1158_2159_8290_CD_20_1066 crossref_primary_10_3390_genes12071071 crossref_primary_10_1038_s43018_022_00475_x crossref_primary_10_1007_s00018_023_04838_0 crossref_primary_10_1016_j_compbiomed_2023_107680 crossref_primary_10_1038_s41586_023_05937_5 crossref_primary_10_1038_s43018_020_00114_3 crossref_primary_10_1038_s41467_025_59572_x crossref_primary_10_1038_s41588_022_01190_0 crossref_primary_10_1093_bib_bbad388 crossref_primary_10_1016_j_heliyon_2024_e27733 crossref_primary_10_1101_gr_279105_124 crossref_primary_10_3390_ijms25010343 crossref_primary_10_1038_s41467_023_41926_y crossref_primary_10_1016_j_molcel_2021_04_017 crossref_primary_10_3389_fonc_2023_1194405 crossref_primary_10_1016_j_cell_2025_04_012 crossref_primary_10_3389_fonc_2022_814504 crossref_primary_10_1139_gen_2020_0097 crossref_primary_10_1016_j_csbj_2023_08_027 crossref_primary_10_1002_jcla_24425 crossref_primary_10_1038_s43018_022_00403_z crossref_primary_10_1177_00368504241276771 crossref_primary_10_1038_s41586_024_08318_8 crossref_primary_10_1016_j_csbj_2023_12_019 crossref_primary_10_1158_1541_7786_MCR_24_0741 crossref_primary_10_1002_path_5901 crossref_primary_10_1016_j_tig_2022_05_015 crossref_primary_10_1186_s12943_024_02187_5 crossref_primary_10_1186_s12885_024_13177_7 crossref_primary_10_1016_j_semcancer_2021_02_014 crossref_primary_10_3390_genes16070802 crossref_primary_10_1146_annurev_cancerbio_060324_114306 crossref_primary_10_1016_j_ccell_2025_08_008 crossref_primary_10_3389_fgene_2023_1158341 crossref_primary_10_1016_j_bbcan_2020_188392 crossref_primary_10_1016_j_csbj_2023_04_012 crossref_primary_10_1038_s41388_023_02640_7 crossref_primary_10_1016_j_semcdb_2022_03_002 crossref_primary_10_1038_s41388_022_02286_x crossref_primary_10_1038_s41467_020_18099_z crossref_primary_10_1038_s41588_020_0678_2 crossref_primary_10_1093_carcin_bgac072 crossref_primary_10_1016_j_annonc_2020_03_303 crossref_primary_10_3390_ijms21072477 crossref_primary_10_1016_j_molcel_2025_03_007 crossref_primary_10_1158_2159_8290_CD_22_0796 crossref_primary_10_1016_j_molcel_2025_03_001 crossref_primary_10_1038_s41467_024_46691_0 crossref_primary_10_1038_s41467_025_60160_2 crossref_primary_10_1038_s41588_021_00842_x crossref_primary_10_1016_j_nbd_2020_105060 crossref_primary_10_1186_s11658_023_00530_0 crossref_primary_10_1038_s41467_023_42656_x crossref_primary_10_1038_s41594_022_00806_7 crossref_primary_10_1186_s12943_021_01413_8 crossref_primary_10_1038_s41568_022_00488_9 crossref_primary_10_1093_nar_gkae646 crossref_primary_10_1080_15384101_2020_1805238 crossref_primary_10_1016_j_molcel_2022_01_003 crossref_primary_10_1246_bcsj_20200235 crossref_primary_10_1182_blood_2021014391 crossref_primary_10_1007_s00418_024_02280_2 crossref_primary_10_1038_s41588_021_00927_7 crossref_primary_10_3390_genes14061304 crossref_primary_10_1038_s44320_025_00098_1 crossref_primary_10_3390_cells10092342 crossref_primary_10_1007_s00412_022_00773_4 crossref_primary_10_1038_s41392_022_01176_8 crossref_primary_10_1016_j_critrevonc_2025_104898 crossref_primary_10_1016_j_gde_2024_102199 crossref_primary_10_3389_fgene_2024_1454153 crossref_primary_10_1186_s12935_022_02617_8 crossref_primary_10_1002_gcc_70004 crossref_primary_10_1016_j_tig_2022_02_007 crossref_primary_10_1093_procel_pwad032 crossref_primary_10_1016_j_cell_2023_12_013 crossref_primary_10_1016_j_biopha_2024_116588 crossref_primary_10_1038_s41467_021_27055_4 crossref_primary_10_1038_s41388_024_03138_6 crossref_primary_10_1016_j_gendis_2025_101734 crossref_primary_10_1016_j_molcel_2020_10_033 crossref_primary_10_3389_fonc_2022_1092705 crossref_primary_10_1186_s12935_021_01936_6 crossref_primary_10_3390_cancers14092310 crossref_primary_10_1093_nar_gkaa153 crossref_primary_10_1038_s41588_021_00926_8 crossref_primary_10_1016_j_molcel_2021_11_027 crossref_primary_10_1158_2159_8290_CD_22_0076 crossref_primary_10_1186_s12864_023_09135_5 crossref_primary_10_1158_2159_8290_CD_25_0230 crossref_primary_10_1016_j_bbagrm_2022_194839 crossref_primary_10_3389_fgeed_2024_1481443 crossref_primary_10_1186_s13046_020_01726_4 crossref_primary_10_1111_1744_7917_13191
ContentType	Journal Article
Copyright	Copyright © 2019 Elsevier Inc. All rights reserved.
Copyright_xml	– notice: Copyright © 2019 Elsevier Inc. All rights reserved.
DBID	CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1016/j.cell.2019.10.039
DatabaseName	Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	no_fulltext_linktorsrc
Discipline	Biology
EISSN	1097-4172
ExternalDocumentID	31761532
Genre	Journal Article Research Support, N.I.H., Extramural
GrantInformation_xml	– fundername: NCI NIH HHS grantid: R01 CA154130 – fundername: NCI NIH HHS grantid: R01 CA169117 – fundername: NCI NIH HHS grantid: R35 CA197718 – fundername: NIDA NIH HHS grantid: R01 DA043980 – fundername: NCI NIH HHS grantid: R01 CA171652 – fundername: NCI NIH HHS grantid: R01 CA160356 – fundername: NCI NIH HHS grantid: R01 CA193677 – fundername: NCI NIH HHS grantid: F30 CA236313 – fundername: NINDS NIH HHS grantid: R01 NS087913 – fundername: NCI NIH HHS grantid: R01 CA204279
GroupedDBID	--- --K -DZ -ET -~X 0R~ 0SF 0WA 1RT 1~5 29B 2FS 2WC 3EH 4.4 457 4G. 53G 5GY 5RE 62- 6J9 7-5 85S AACTN AAEDT AAEDW AAFTH AAFWJ AAHBH AAKRW AAKUH AALRI AAMRU AAVLU AAXUO ABCQX ABJNI ABMAC ABOCM ABVKL ACGFO ACGFS ACNCT ADBBV ADEZE ADVLN AEFWE AENEX AEXQZ AFTJW AGHSJ AGKMS AHHHB AITUG AKAPO AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ ASPBG AVWKF AZFZN BAWUL CGR CS3 CUY CVF DIK DU5 E3Z EBS ECM EIF F5P FCP FDB FIRID HH5 IH2 IHE IXB J1W JIG K-O KOO KQ8 L7B LX5 M3Z M41 N9A NPM O-L O9- OK1 P2P RCE RIG RNS ROL RPZ SCP SDG SDP SES SSZ TAE TN5 TR2 TWZ UKR UPT VQA WH7 YZZ ZCA 7X8 AAYWO ABDGV ACVFH ADCNI ADXHL AEUPX AFPUW AIGII AKBMS AKYEP APXCP EFKBS
ID	FETCH-LOGICAL-c554t-5d6a8ce01171f36e84be79260c4aa375a080a01a8a6308a76b5bb454a3d031c12
IEDL.DBID	7X8
ISICitedReferencesCount	229
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000499646200012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	1097-4172
IngestDate	Thu Oct 02 11:23:31 EDT 2025 Wed Feb 19 02:30:50 EST 2025
IsDoiOpenAccess	false
IsOpenAccess	true
IsPeerReviewed	true
IsScholarly	true
Issue	6
Keywords	enhancer MYCN double minute glioblastoma epigenetic MYC oncogene amplification extrachromosomal DNA EGFR
Language	English
License	Copyright © 2019 Elsevier Inc. All rights reserved.
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c554t-5d6a8ce01171f36e84be79260c4aa375a080a01a8a6308a76b5bb454a3d031c12
Notes	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
OpenAccessLink	http://www.cell.com/article/S0092867419312164/pdf
PMID	31761532
PQID	2317967293
PQPubID	23479
ParticipantIDs	proquest_miscellaneous_2317967293 pubmed_primary_31761532
PublicationCentury	2000
PublicationDate	2019-11-27
PublicationDateYYYYMMDD	2019-11-27
PublicationDate_xml	– month: 11 year: 2019 text: 2019-11-27 day: 27
PublicationDecade	2010
PublicationPlace	United States
PublicationPlace_xml	– name: United States
PublicationTitle	Cell
PublicationTitleAlternate	Cell
PublicationYear	2019
SSID	ssj0008555
Score	2.6724362
Snippet	Non-coding regions amplified beyond oncogene borders have largely been ignored. Using a computational approach, we find signatures of significant...
SourceID	proquest pubmed
SourceType	Aggregation Database Index Database
StartPage	1330
SubjectTerms	Acetylation Cell Line, Tumor Cell Survival - genetics Chromatin - metabolism Chromosomes, Human - genetics CRISPR-Cas Systems - genetics DNA, Neoplasm - genetics Enhancer Elements, Genetic ErbB Receptors - genetics ErbB Receptors - metabolism Gene Amplification Genes, Neoplasm Genetic Loci Glioblastoma - genetics Glioblastoma - pathology Histones - metabolism Humans Neuroglia - metabolism Oncogenes
Title	Functional Enhancers Shape Extrachromosomal Oncogene Amplifications
URI	https://www.ncbi.nlm.nih.gov/pubmed/31761532 https://www.proquest.com/docview/2317967293
Volume	179
WOSCitedRecordID	wos000499646200012&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings	1
isFullTextHit
isPrint
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8MwDI6AgcSF92O8VCSuAdqkSXpC07SJC2MSIO1WuVmicaAd60Dw77HbTrshJC69tJEi27G_Op9txq4kOGOd8NyAUFzqyHNAy-HeafC0xEZQDZvQg4EZjZJhk3ArG1rlwidWjnpcWMqR3yAO0YlCKCjupu-cpkbR7WozQmOVtQRCGaJ06dGyW7iJq6mndMnKJUbqpmim5ndRYpyoXck1sbvELxCzCjX97f9ucodtNSAz6NRWsctWXL7HNuqxk9_7rNvHYFbnAINePiG9z8rgaQJTF_S-5jOwEyLplcUbfvCY2wKNzAUd4p77RYrvgL30e8_de94MU-AWEcOcx2MFqBVqARd6oZyRmdMJ_s1YCSB0DAgd4TYEA0rcGtAqi7NMxhLEGM-9DaNDtpYXuTtmgYxj8gRKRVJQpWoifCZBeRc64zITt9nlQjopGisJGnJXfJTpUj5tdlSLOJ3WXTVSfEXgMzr5w-pTtkmao5rASJ-xlsej6s7Zuv2cv5azi8oK8DkYPvwAAr-8OQ
linkProvider	ProQuest
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Functional+Enhancers+Shape+Extrachromosomal+Oncogene+Amplifications&rft.jtitle=Cell&rft.au=Morton%2C+Andrew+R&rft.au=Dogan-Artun%2C+Nergiz&rft.au=Faber%2C+Zachary+J&rft.au=MacLeod%2C+Graham&rft.date=2019-11-27&rft.eissn=1097-4172&rft.volume=179&rft.issue=6&rft.spage=1330&rft_id=info:doi/10.1016%2Fj.cell.2019.10.039&rft_id=info%3Apmid%2F31761532&rft_id=info%3Apmid%2F31761532&rft.externalDocID=31761532
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1097-4172&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1097-4172&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1097-4172&client=summon